"Medical Research Center"

During the past decade, Meris Clinical Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meris Clinical Research" #1 sponsor was "Harmony Biosciences, LLC" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "CSL Behring" with 1 trials sponsored and "Romark Laboratories L.C." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meris Clinical Research" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator and "LGC Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Meris Clinical Research" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Idiopathic Hypersomnia" (2 trials), "COPD" (1 trials), "COVID-19" (1 trials) and "Excessive Daytime Sleepiness" (1 trials). Many other conditions were trialed in "Meris Clinical Research" in a lesser frequency.

Most popular intervention types in "Meris Clinical Research" are "Drug" (9 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "CSL312" (1 trials), "Ensifentrine (formerly RPL554) 0.375 mg twice daily plus placebo, in addition to tiotropium" (1 trials) and "Ensifentrine (formerly RPL554) 0.75 mg twice daily plus placebo, in addition to tiotropium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Meris Clinical Research" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Meris Clinical Research". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Meris Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Meris Clinical Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".